NEWYou can now listen to Fox News articles! An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes. Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital that he’s …
Read More »
tvt news Haberler
